Nanoscope® team conferred Phase II Retinal Organoid Challenge (ROC) award by National Institute of Health
News provided by
Share this article
Share this article
BEDFORD, Texas, Feb. 2, 2021 /PRNewswire/ To meet the advance challenge for generating a physiologically relevant three-dimensional (3D) retinal organoid, Nanoscope researchers
® in collaboration with University of Colorado, and Miami University
were recently awarded the top prize from the 3D-ROC challenge by the National Institute of Health (NIH). https://www.nei.nih.gov/about/goals-and-accomplishments/nei-research-initiatives/3-d-retina-organoid-challenge-3-d-roc/2017-ideation-challenge/2017-ideation-winner-and-honorable-mention
The organoids provide a unique opportunity for evaluating novel gene therapies including Multi-Characteristic Opsin (MCO) gene therapy for vision restoration. This is an active therapeutic development area for Nanoscope Therapeutics to evaluate effectiveness of MCO optogenetic t